Genomics companies shop around for chemical expertise

Article Abstract:

Two genomics companies deCODE Genetics and Lexicon Genetics announced significant progress in efforts to strengthen their product pipelines, reassuring dubious investors about genomics companies' commitment and ability to establish genes to drugs platforms that highlighted the need for medicinal chemistry. Details about the different companies who have made a reputation in medicinal chemistry are given.

Science & research, Research and Testing Services, Medical Research, Epilepsy & Muscle Disease R&D, Iceland, Administration of Public Health Programs, Health Research Programs, Research, Methods, Product development, Biotechnology industry, Biotechnology industries, deCODE genetics Inc., Genomics, Medicine, Experimental, Lexicon Pharmaceuticals Inc., DCGN

---

Eli Lilly enter venture capital arena

Article Abstract:

Eli Lilly has created a venture capital group, Lilly BioVentures which will invest up to $75 million in new biotechnology companies. Lilly is one of several pharmaceutical firms making venture capital investments in life science companies.

Biochemistry, Organizational history, Venture Capital Companies, Miscellaneous Intermediation, Investors, not elsewhere classified, Statistical Data Included, Eli Lilly and Co., LLY, Lilly BioVentures

---

Cantab failure shows need for wide portfolio

Article Abstract:

With the failure of Cantab's vaccine TH-GW to treat genital warts, the company's stock value has dropped by two thirds, forcing the resignation of CEO Jurek Sikorski, and causing the company to be put up for sale.

United Kingdom, Asset sales & divestitures, Sales, profits & dividends, Pharmaceutical Preparation Manufacturing, Executive changes & profiles, Financial analysis, Biological products exc. diagnostic, Vaccines for Human Use, Vaccines, Cantab Pharmaceutical Research Ltd.

Similar abstracts:

• Abstracts: Tech companies with minimal risk. Take a slice of their profits. Shares that must climb
• Abstracts: It pays to shop around. Balancing income and capital growth in retirement. Taking a sipp from the www.cup
• Abstracts: BioPulse faces US and Mexican malpractice probes. Analysts: Isis-Lilly deal validates antisense. Company, academics argue over data
• Abstracts: Trimmed down Chiron pitches cancer genomics. Patent case unblocks antibody businesses. First Genetic Trust banks on genes

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.